Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Seed | Alive

About Ixo Foundation

Provider of a protocol that tokenizes impact data with Proof of Impact. The company's protocol could be used to track attendance in pre-schools in South Africa.The teacher logs each child’s attendance in the app, an evaluator confirms the attendance, and a verified impact claim is created. The verified claim can then be shown to the government in return for subsidies for underprivileged children. Proof is generated when an impact claim is made by a service provider and is verified by an evaluator or an oracle, validating the impact has been achieved.

Ixo Foundation Headquarters Location

Gubelstrasse 11

Zurich, 6300,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ixo Foundation Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Ixo Foundation Rank

  • Where is Ixo Foundation's headquarters?

    Ixo Foundation's headquarters is located at Gubelstrasse 11, Zurich.

  • What is Ixo Foundation's latest funding round?

    Ixo Foundation's latest funding round is Seed.

  • Who are the investors of Ixo Foundation?

    Investors of Ixo Foundation include Unicef Ventures and Singularity University.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.